학술논문

Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial
Document Type
Article
Source
In: The Lancet Microbe. (The Lancet Microbe, September 2022, 3(9):e663-e671)
Subject
Language
English
ISSN
26665247